Follow The Filings

STXS Stereotaxis Inc.

Health Care, filed as STEREOTAXIS INC (COM NEW), Equity As of 2026 Q2 among managers we track Quote on Google Finance, opens in a new tab

  • 1 Owner
  • Max 4.5%
  • $24M

Who owns this now

Largest portfolio weights among holders, up to 4.5% (Nathan Fischel, Dafna Capital Management). Not free-float ownership.

  1. Nathan Fischel 4.5%

Who owns STXS

Sorted by value, long equity only, as of 2026 Q2.

History
Nathan Fischel, Dafna Capital Management 4.5% Hold 13,680,554 $24M History

1 current, options excluded

Weight bar: held both quarters added sold at this quarter’s reported price

Insider trades

Open-market buys and sales by STXS's executives, directors and 10% owners in the last 12 months, from their Form 4s

All STXS insider trades
  • $67K bought by 1 insider
  • None no sales outside a trading plan
  • None no planned (10b5-1) sales
  1. Paul J Isaac Director
    Buy
    $67K 30,000 shares at $2.22
    Traded Nov 14–17 Filed Nov 18, 2025
    ↗

Also filed in the last 12 months, not counted as buying or selling: 12 stock grants.

SEC filings

Recent issuer filings from EDGAR, 25 shown.

Filed Form Detail Links
SCHEDULE 13G — Filing Doc
424B3 Filing Doc
424B3 Filing Doc
10-Q Filing Doc
8-K 2.02,9.01 Filing Doc
8-K 8.01,9.01 Filing Doc
8-K 3.02,7.01,8.01,9.01 Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 5.07 Filing Doc
10-Q Filing Doc
8-K 2.02,9.01 Filing Doc
8-K 1.01,3.02,7.01,9.01 Filing Doc
DEF 14A Filing Doc
DEFA14A Filing Doc
10-K/A Filing Doc
10-K Filing Doc
8-K 2.02,9.01 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
8-K 1.01,9.01 Filing Doc
424B5 Filing Doc
10-Q Filing Doc
8-K 2.02,9.01 Filing Doc
424B5 Filing Doc
8-K 2.02,8.01 Filing Doc

Source: SEC EDGAR submissions, updated 5 days ago. All on EDGAR

Financials

US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.

Income statement

Metric FY2023 FY2024 FY2025
Revenue $26.77M $26.92M $32.38M
Gross profit $14.86M $14.59M $17.07M
Gross margin * 55.5% 54.2% 52.7%
Net income -$20.71M -$24.04M -$21.64M
Net margin * -77.4% -89.3% -66.8%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $33.27M $26.44M $33.85M
Total non-current assets * $8.64M $20.28M $18.4M
Total assets $41.91M $46.72M $52.25M
Total current liabilities $13.25M $21.6M $22.36M
Total non-current liabilities * $6.74M $13.69M $11.17M
Total equity $16.34M $6.08M $13.48M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$9.14M -$8.5M -$13.68M
Cash from investing $19.76M $0.074M -$0.093M
Cash from financing $0.081M $0.297M $14.76M
Net change in cash $10.71M -$8.13M $0.985M

Source: SEC companyfacts (US-GAAP 10-K). A * marks a computed figure, not a single XBRL tag. Fiscal years are as the issuer labels them. Follow The Filings does not adjust or audit these figures.

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.